Nascimento, Marcos Assis http://orcid.org/0000-0002-9830-9801
Biagiotti, Sean
Herranz-PĂ©rez, Vicente http://orcid.org/0000-0002-1969-1214
Santiago, Samara http://orcid.org/0000-0002-9502-7104
Bueno, Raymund
Ye, Chun J. http://orcid.org/0000-0001-6560-3783
Abel, Taylor J.
Zhang, Zhuangzhi http://orcid.org/0000-0002-9860-6689
Rubio-Moll, Juan S.
Kriegstein, Arnold R.
Yang, Zhengang http://orcid.org/0000-0003-2447-6540
Garcia-Verdugo, Jose Manuel http://orcid.org/0000-0001-9872-6499
Huang, Eric J. http://orcid.org/0000-0002-5381-3801
Alvarez-Buylla, Arturo
Sorrells, Shawn F. http://orcid.org/0000-0002-0010-6628
Article History
Received: 26 March 2022
Accepted: 7 December 2023
First Online: 20 December 2023
Competing interests
: A.A.-B. is a co-founder and is on the scientific advisory board of Neurona Therapeutics. A.R.K. is a co-founder, consultant and director of Neurona Therapeutics. C.J.Y. is a founder for and holds equity in DropPrint Genomics (now ImmunAI) and Survey Genomics; is a member of the scientific advisory board for and holds equity in Related Sciences and ImmunAI; is a consultant for and holds equity in Maze Therapeutics; is a consultant for TReX Bio, HiBio, ImYoo and Santa Ana; and is also an Innovation Investigator for the Arc Institute. C.J.Y. has received research support from the Chan Zuckerberg Initiative, the Chan Zuckerberg Biohub, Genentech, BioLegend, ScaleBio and Illumina.